Real ChatGPT answer · index seedVUPofaQF9cgcompleteHealth and wellnesscommercial
What do current medical reviews say about the safety of starting hormone replacement therapy in your early sixties for severe menopausal symptoms
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What do current medical reviews say about the safety of starting hormone replacement therapy in your early sixties for severe menopausal symptoms
3 real searches · 1 real-search pass
2025 2026 medical review starting menopausal hormone therapy age 60 older timing hypothesis risks benefits severe vasomotor symptomsGoogle ↗
OBSERVED
North American Menopause Society hormone therapy position statement age 60 10 years menopause initiation risks transdermal estrogenGoogle ↗
OBSERVED
ACOG menopause hormone therapy older than 60 starting therapy risks benefits cardiovascularGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
2025 2026 medical review starting menopausal hormone therapy age 60 older timing hypothesis risks benefits severe vasomotor symptoms Google ↗
North American Menopause Society hormone therapy position statement age 60 10 years menopause initiation risks transdermal estrogen Google ↗
ACOG menopause hormone therapy older than 60 starting therapy risks benefits cardiovascular Google ↗
8 cited sources
- The 2022 hormone therapy position statement of The North American Menopause Society · pubmed.ncbi.nlm.nih.gov
- NAMS Hormone Therapy Position Statement 2022 Guideline Summary · www.guidelinecentral.com
- Management of menopausal hormone therapy. · pubmed.ncbi.nlm.nih.gov
- Menopause Topics: Hormone Therapy · menopause.org
- Hormone therapy safety · womenshealth.gov
- NAMS 2022 Hormone Therapy Position Statement · www.menopause.org.au
- FDA Requests Labeling Changes Related to Safety Information to Clarify the Benefit/Risk Considerations for Menopausal Hormone Therapies · www.fda.gov
- Updated Labeling for Menopausal Hormone Therapy | Women's Health | JAMA · jamanetwork.com
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
2025 2026 medical review starting menopausal hormone therapy age 60 older timing hypothesis risks benefits severe vasomotor symptoms OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
North American Menopause Society hormone therapy position statement age 60 10 years menopause initiation risks transdermal estrogen OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
ACOG menopause hormone therapy older than 60 starting therapy risks benefits cardiovascular OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |